Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Defective T-cell response in beige mutant mice

Abstract

A role for T cells in immune surveillance has long been suggested1, but the lack of high tumour incidence in T cell-deficient nude mice represented a challenge to this hypothesis. The discovery of natural killer (NK) cells, which can lyse tumour cells without any previous sensitization, and high NK levels in nude mice, suggested that these cells may constitute a first line of defence against spontaneously arising tumours in vivo2. Reports3–5 of a selective NK deficiency and normal T-cell function in C57BL/6 mice carrying the beige mutation (bg/bg) suggested that these mice might be useful for assessing the relative importance of T-cell and NK-cell systems in immune surveillance. However we report here that the deficiency of beige mice is not restricted to NK cells. The generation of cytotoxic T lymphocytes (CTLs) in response to alloimmune challenge in vivo or in vitro was markedly impaired in beige mutants. Thus our results do not support the suggestion3,5 that beige mice might be useful as a model of a selective NK deficiency.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Burnet, F. M. Prog. exp. Tumor Res. 13, 1–27 (1970).

    Article  CAS  Google Scholar 

  2. Herberman, R. B. & Holden, H. T. Adv. Cancer Res. 27, 305–377 (1978).

    Article  CAS  Google Scholar 

  3. Roder, J. & Duwe, A. Nature 278, 451–453 (1979).

    Article  ADS  CAS  Google Scholar 

  4. Roder, J. C. J. Immun. 123, 2168–2173 (1979).

    CAS  PubMed  Google Scholar 

  5. Roder, J. C., Lohmann-Matthes, M-L., Domzig, W. & Wigzell, H. J. Immun. 123, 2174–2181 (1979).

    CAS  PubMed  Google Scholar 

  6. Saxena, R. K. & Adler, W. H. J. Immun. 123, 846–851 (1979).

    CAS  PubMed  Google Scholar 

  7. Saxena, R. K., Adler, W. H. & Nordin, A. A. Cell. Immun. 63, 28–41 (1981).

    Article  CAS  Google Scholar 

  8. Herberman, R. B., Nunn, M. E., Holden, H. T., Staal, S. & Djeu, J. Y. Int. J. Cancer 19, 555–564 (1977).

    Article  CAS  Google Scholar 

  9. Cerottini, J-C. & Brunner, K. T. Adv. Immun. 18, 67–152 (1974).

    Article  CAS  Google Scholar 

  10. Saxena, R. K., Adler, W. H. & Nordin, A. A. Immun. Commun. 9, 371–378 (1980).

    Article  CAS  Google Scholar 

  11. Nordin, A. A. & Adler, W. H. in Developmental Immunobiology (eds Siskind, G. W., Litwin, S. D. & Weksler, M. L.) 215–229 (Grune & Stratton, New York, 1979).

    Google Scholar 

  12. Welsh, R. M. & Kiessling, R. W. Scand. J. Immun. 11, 363–367 (1980).

    Article  Google Scholar 

  13. McKinnon, K. P., Hale, A. H. & Ruebush, M. J. Infect. Immunity 32, 204–210 (1981).

    CAS  Google Scholar 

  14. Karre, K., Klein, G. O., Kiessling, R. M. & Roder, J. C. Int. J. Cancer 26, 78–79 (1980).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saxena, R., Saxena, Q. & Adler, W. Defective T-cell response in beige mutant mice. Nature 295, 240–241 (1982). https://doi.org/10.1038/295240a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/295240a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing